ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
24 Mar 2020 07:30

Celltrion Seo's Projected Timeline for a COVID-19 Vaccine: Key Takeaways from PR

The three Celltrion siblings had quite a pleasant day yesterday. Celltrion Inc (068270 KS) was up 14.75%, while Celltrion Pharm (068760 KS) almost...

Logo
301 Views
Share
11 Feb 2020 07:18

KOSDAQ150 Rebalance Preview - Stocks Starting to Move

The Korea Exchange (KRX) will announce the results of the June 2020 review of the KOSDAQ 150 index in May. The constituent changes will be...

Logo
496 Views
Share
01 Feb 2020 13:41

Korea Stock Market Monthly Recap #44 (January 2020)

The top 10 events impacting the Korean stock market, economy, & politics in January were as follows: 1) NEW CORONAVIRUS (WUHAN VIRUS) 2)...

Logo
348 Views
Share
29 Jan 2020 17:47

Korea - Pharma Stocks See Short Covering

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 23 January...

Logo
345 Views
Share
21 Jan 2020 17:51

Korea - Celltrion Shorts Increase, Semco Covering Continues

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 17 January 2020....

Logo
390 Views
Share
x